Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Radiation Oncology
Published in: Radiation Oncology 1/2022

Open Access 01-12-2022 | Review

A review of radiomics and genomics applications in cancers: the way towards precision medicine

Authors: Simin Li, Baosen Zhou

Published in: Radiation Oncology | Issue 1/2022

Login to get access

Abstract

The application of radiogenomics in oncology has great prospects in precision medicine. Radiogenomics combines large volumes of radiomic features from medical digital images, genetic data from high-throughput sequencing, and clinical-epidemiological data into mathematical modelling. The amalgamation of radiomics and genomics provides an approach to better study the molecular mechanism of tumour pathogenesis, as well as new evidence-supporting strategies to identify the characteristics of cancer patients, make clinical decisions by predicting prognosis, and improve the development of individualized treatment guidance. In this review, we summarized recent research on radiogenomics applications in solid cancers and presented the challenges impeding the adoption of radiomics in clinical practice. More standard guidelines are required to normalize radiomics into reproducible and convincible analyses and develop it as a mature field.
Literature
1.
Fernández-Lázaro D, Hernández JLG, García AC, Castillo ACD, Hueso MV, Cruz-Hernández JJ. Clinical perspective and translational oncology of liquid biopsy. Diagnostics (Basel). 2020;10(7):E443.CrossRef
2.
Mazouji O, Ouhajjou A, Incitti R, Mansour H. Updates on clinical use of liquid biopsy in colorectal cancer screening, diagnosis, follow-up, and treatment guidance. Front Cell Dev Biol. 2021;9: 660924.CrossRef
3.
Lambin P, Rios-Velazquez E, Leijenaar R, Carvalho S, van Stiphout RGPM, Granton P, et al. Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer. 2012;48(4):441–6.CrossRef
4.
Shendure J, Findlay GM, Snyder MW. Genomic medicine-progress, pitfalls, and promise. Cell. 2019;177(1):45–57.CrossRef
5.
Singh A, Chitalia R, Kontos D. Radiogenomics in brain, breast, and lung cancer: opportunities and challenges. J Med Imaging (Bellingham). 2021;8(3): 031907.
6.
7.
Shui L, Ren H, Yang X, Li J, Chen Z, Yi C, et al. The era of radiogenomics in precision medicine: an emerging approach to support diagnosis, treatment decisions, and prognostication in oncology. Front Oncol. 2020;10: 570465.CrossRef
8.
Bodalal Z, Trebeschi S, Nguyen-Kim TDL, Schats W, Beets-Tan R. Radiogenomics: bridging imaging and genomics. Abdom Radiol (NY). 2019;44(6):1960–84.CrossRef
9.
Lambin P, Leijenaar RTH, Deist TM, Peerlings J, de Jong EEC, van Timmeren J, et al. Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol. 2017;14(12):749–62.CrossRef
10.
Pinker K, Chin J, Melsaether AN, Morris EA, Moy L. Precision medicine and radiogenomics in breast cancer: new approaches toward diagnosis and treatment. Radiology. 2018;287(3):732–47.CrossRef
11.
Hsu JBK, Lee GA, Chang TH, Huang SW, Le NQK, Chen YC, et al. Radiomic immunophenotyping of GSEA-assessed immunophenotypes of glioblastoma and its implications for prognosis: a feasibility study. Cancers (Basel). 2020;12(10):E3039.CrossRef
12.
Smits M. MRI biomarkers in neuro-oncology. Nat Rev Neurol. 2021;17(8):486–500.CrossRef
13.
Shur JD, Doran SJ, Kumar S, ap Dafydd D, Downey K, O’Connor JPB, et al. Radiomics in oncology: a practical guide. Radiographics. 2021;41(6):1717–32.CrossRef
14.
Isaksson LJ, Raimondi S, Botta F, Pepa M, Gugliandolo SG, De Angelis SP, et al. Effects of MRI image normalization techniques in prostate cancer radiomics. Phys Med. 2020;71:7–13.CrossRef
15.
He H, Razlighi QR. Landmark-guided region-based spatial normalization for functional magnetic resonance imaging. Hum Brain Mapp. 2022;43(11):3524–44.CrossRef
16.
Delisle PL, Anctil-Robitaille B, Desrosiers C, Lombaert H. Realistic image normalization for multi-Domain segmentation. Med Image Anal. 2021;74: 102191.CrossRef
17.
Pizurica A, Philips W, Lemahieu I, Acheroy M. A versatile wavelet domain noise filtration technique for medical imaging. IEEE Trans Med Imaging. 2003;22(3):323–31.CrossRef
18.
Dabov K, Foi A, Katkovnik V, Egiazarian K. Image denoising by sparse 3-D transform-domain collaborative filtering. IEEE Trans Image Process. 2007;16(8):2080–95.CrossRef
19.
Fan L, Zhang F, Fan H, Zhang C. Brief review of image denoising techniques. Vis Comput Ind Biomed Art. 2019;2(1):7.CrossRef
20.
Zwanenburg A, Vallières M, Abdalah MA, Aerts HJWL, Andrearczyk V, Apte A, et al. The image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping. Radiology. 2020;295(2):328–38.CrossRef
21.
Jang S, Kim S, Kim M, Son K, Lee KY, Ra JB. Head motion correction based on filtered backprojection in helical CT scanning. IEEE Trans Med Imaging. 2020;39(5):1636–45.CrossRef
22.
El Ayachy R, Giraud N, Giraud P, Durdux C, Giraud P, Burgun A, et al. The role of radiomics in lung cancer: from screening to treatment and follow-up. Front Oncol. 2021;11: 603595.CrossRef
23.
van Timmeren JE, Cester D, Tanadini-Lang S, Alkadhi H, Baessler B. Radiomics in medical imaging-"how-to" guide and critical reflection. Insights Imaging. 2020;11(1):91.CrossRef
24.
Kuo MD, Jamshidi N. Behind the numbers: decoding molecular phenotypes with radiogenomics–guiding principles and technical considerations. Radiology. 2014;270(2):320–5.CrossRef
25.
Baeßler B, Weiss K, Pinto Dos Santos D. Robustness and reproducibility of radiomics in magnetic resonance imaging: a phantom study. Invest Radiol. 2019;54(4):221–8.CrossRef
26.
Xie CY, Pang CL, Chan B, Wong EYY, Dou Q, Vardhanabhuti V. Machine learning and radiomics applications in esophageal cancers using non-invasive imaging methods-A critical review of literature. Cancers (Basel). 2021;13(10):2469.CrossRef
27.
Fedorov A, Beichel R, Kalpathy-Cramer J, Finet J, Fillion-Robin JC, Pujol S, et al. 3D slicer as an image computing platform for the quantitative imaging network. Magn Reson Imaging. 2012;30(9):1323–41.CrossRef
28.
Yushkevich PA, Gao Y, Gerig G. ITK-SNAP: an interactive tool for semi-automatic segmentation of multi-modality biomedical images. Annu Int Conf IEEE Eng Med Biol Soc. 2016;2016:3342–5.
29.
Nioche C, Orlhac F, Boughdad S, Reuzé S, Goya-Outi J, Robert C, et al. LIFEx: a freeware for radiomic feature calculation in multimodality imaging to accelerate advances in the characterization of tumor heterogeneity. Cancer Res. 2018;78(16):4786–9.CrossRef
30.
Wolf I, Vetter M, Wegner I, Böttger T, Nolden M, Schöbinger M, et al. The medical imaging interaction toolkit. Med Image Anal. 2005;9(6):594–604.CrossRef
31.
Broeke J, Mateos Pérez JM, Pascau J. Image processing with ImageJ: extract and analyze data from complex images with ImageJ, the world’s leading image processing tool. Second edition. Birmingham Mumbai: Packt Publishing open source; 2015. 231 p. (Community experience distilled).
32.
Binczyk F, Prazuch W, Bozek P, Polanska J. Radiomics and artificial intelligence in lung cancer screening. Transl Lung Cancer Res. 2021;10(2):1186–99.CrossRef
33.
Yamashita R, Nishio M, Do RKG, Togashi K. Convolutional neural networks: an overview and application in radiology. Insights Imaging. 2018;9(4):611–29.CrossRef
34.
35.
Zhou Y, Xu J, Liu Q, Li C, Liu Z, Wang M, et al. A radiomics approach with CNN for shear-wave elastography breast tumor classification. IEEE Trans Biomed Eng. 2018;65(9):1935–42.CrossRef
36.
Chaddad A, Kucharczyk MJ, Cheddad A, Clarke SE, Hassan L, Ding S, et al. Magnetic resonance imaging based radiomic models of prostate cancer: a narrative review. Cancers (Basel). 2021;13(3):552.CrossRef
37.
Arimura H, Soufi M, Kamezawa H, Ninomiya K, Yamada M. Radiomics with artificial intelligence for precision medicine in radiation therapy. J Radiat Res. 2019;60(1):150–7.CrossRef
38.
Bak SH, Park H, Lee HY, Kim Y, Kim HL, Jung SH, et al. Imaging genotyping of functional signaling pathways in lung squamous cell carcinoma using a radiomics approach. Sci Rep. 2018;8(1):3284.CrossRef
39.
van Griethuysen JJM, Fedorov A, Parmar C, Hosny A, Aucoin N, Narayan V, et al. Computational radiomics system to decode the radiographic phenotype. Cancer Res. 2017;77(21):e104–7.CrossRef
40.
Mao B, Ma J, Duan S, Xia Y, Tao Y, Zhang L. Preoperative classification of primary and metastatic liver cancer via machine learning-based ultrasound radiomics. Eur Radiol. 2021;31(7):4576–86.CrossRef
41.
Zhang L, Fried DV, Fave XJ, Hunter LA, Yang J, Court LE. IBEX: an open infrastructure software platform to facilitate collaborative work in radiomics. Med Phys. 2015;42(3):1341–53.CrossRef
42.
Zwanenburg A, Leger S, Agolli L, Pilz K, Troost EGC, Richter C, et al. Assessing robustness of radiomic features by image perturbation. Sci Rep. 2019;9(1):614.CrossRef
43.
Pfaehler E, Zwanenburg A, de Jong JR, Boellaard R. RaCaT: an open source and easy to use radiomics calculator tool. PLoS ONE. 2019;14(2): e0212223.CrossRef
44.
45.
Zwanenburg A, Leger S, Vallières M, Löck S. Image biomarker standardisation initiative. Radiology. 2020;295(2):328–38.CrossRef
46.
Bettinelli A, Branchini M, De Monte F, Scaggion A, Paiusco M. Technical note: an IBEX adaption toward image biomarker standardization. Med Phys. 2020;47(3):1167–73.CrossRef
47.
Bettinelli A, Marturano F, Avanzo M, Loi E, Menghi E, Mezzenga E, et al. A novel benchmarking approach to assess the agreement among radiomic tools. Radiology. 2022;303(3):533–41.CrossRef
48.
Wu X, Li J, Mou Y, Yao Y, Cui J, Mao N, et al. Radiomics nomogram for identifying sub-1 cm benign and malignant thyroid lesions. Front Oncol. 2021;11: 580886.CrossRef
49.
Barabino E, Rossi G, Fedeli A, Cittadini G, Genova C. Radiomic-based diagnostics in oncology: challenges toward clinical practice. Oncoscience. 2021;8:72–3.CrossRef
50.
Mun SK, Wong KH, Lo SCB, Li Y, Bayarsaikhan S. Artificial intelligence for the future radiology diagnostic service. Front Mol Biosci. 2020;7: 614258.CrossRef
51.
Duan C, Liu F, Gao S, Zhao J, Niu L, Li N, et al. Comparison of radiomic models based on different machine learning methods for predicting intracerebral hemorrhage expansion. Clin Neuroradiol. 2022;32(1):215–23.CrossRef
52.
Valsecchi C, Consonni V, Todeschini R, Orlandi ME, Gosetti F, Ballabio D. Parsimonious optimization of multitask neural network hyperparameters. Molecules. 2021;26(23):7254.CrossRef
53.
Bergstra JS, Bardenet R, Bengio Y, Kégl B. Algorithms for hyper-parameter optimization:9.
54.
Bergstra J, Bengio Y. Random Search for Hyper-Parameter Optimization:25.
55.
Olisah CC, Smith L, Smith M. Diabetes mellitus prediction and diagnosis from a data preprocessing and machine learning perspective. Comput Methods Progr Biomed. 2022;220: 106773.CrossRef
56.
Martinez-Cantin R. Funneled Bayesian optimization for design, tuning and control of autonomous systems. IEEE Trans Cybern. 2019;49(4):1489–500.CrossRef
57.
Probst P, Wright MN, Boulesteix AL. Hyperparameters and tuning strategies for random forest. WIREs Data Min Knowl Discov. 2019;9(3): e1301.
58.
Nematzadeh S, Kiani F, Torkamanian-Afshar M, Aydin N. Tuning hyperparameters of machine learning algorithms and deep neural networks using metaheuristics: a bioinformatics study on biomedical and biological cases. Comput Biol Chem. 2022;97: 107619.CrossRef
59.
Yang L, Gu D, Wei J, Yang C, Rao S, Wang W, et al. A radiomics nomogram for preoperative prediction of microvascular invasion in hepatocellular carcinoma. Liver Cancer. 2019;8(5):373–86.CrossRef
60.
Pei X, Wang P, Ren JL, Yin XP, Ma LY, Wang Y, et al. Comparison of different machine models based on contrast-enhanced computed tomography radiomic features to differentiate high from low grade clear cell renal cell carcinomas. Front Oncol. 2021;11: 659969.CrossRef
61.
Hong D, Zhang L, Xu K, Wan X, Guo Y. Prognostic value of Pre-treatment CT radiomics and clinical factors for the overall survival of advanced (IIIB-IV) lung adenocarcinoma patients. Front Oncol. 2021;11: 628982.CrossRef
62.
Avanzo M, Wei L, Stancanello J, Vallières M, Rao A, Morin O, et al. Machine and deep learning methods for radiomics. Med Phys. 2020;47(5):e185-202.CrossRef
63.
Hinton GE, Salakhutdinov RR. Reducing the dimensionality of data with neural networks. Science. 2006;313(5786):504–7.CrossRef
64.
65.
Chen X, Wang X, Zhang K, Fung KM, Thai TC, Moore K, et al. Recent advances and clinical applications of deep learning in medical image analysis. Med Image Anal. 2022;1(79): 102444.CrossRef
66.
67.
68.
Wu S, Zheng J, Li Y, Wu Z, Shi S, Huang M, et al. Development and validation of an MRI-based radiomics signature for the preoperative prediction of lymph node metastasis in bladder cancer. EBioMedicine. 2018;34:76–84.CrossRef
69.
Ligero M, Jordi-Ollero O, Bernatowicz K, Garcia-Ruiz A, Delgado-Muñoz E, Leiva D, et al. Minimizing acquisition-related radiomics variability by image resampling and batch effect correction to allow for large-scale data analysis. Eur Radiol. 2021;31(3):1460–70.CrossRef
70.
Xie D, Wang TT, Huang SJ, Deng JJ, Ren YJ, Yang Y, et al. Radiomics nomogram for prediction disease-free survival and adjuvant chemotherapy benefits in patients with resected stage I lung adenocarcinoma. Transl Lung Cancer Res. 2020;9(4):1112–23.CrossRef
71.
Ma DN, Gao XY, Dan YB, Zhang AN, Wang WJ, Yang G, et al. Evaluating solid lung adenocarcinoma anaplastic lymphoma kinase gene rearrangement using noninvasive radiomics biomarkers. Onco Targets Ther. 2020;13:6927–35.CrossRef
72.
Kim G, Kim J, Cha H, Park WY, Ahn JS, Ahn MJ, et al. Metabolic radiogenomics in lung cancer: associations between FDG PET image features and oncogenic signaling pathway alterations. Sci Rep. 2020;10(1):13231.CrossRef
73.
Arefan D, Hausler RM, Sumkin JH, Sun M, Wu S. Predicting cell invasion in breast tumor microenvironment from radiological imaging phenotypes. BMC Cancer. 2021;21(1):370.CrossRef
74.
Wu J, Mayer AT, Li R. Integrated imaging and molecular analysis to decipher tumor microenvironment in the era of immunotherapy. Semin Cancer Biol. 2022;84:310–28.CrossRef
75.
Fan M, Xia P, Clarke R, Wang Y, Li L. Radiogenomic signatures reveal multiscale intratumour heterogeneity associated with biological functions and survival in breast cancer. Nat Commun. 2020;11(1):4861.CrossRef
76.
Liu L, Yi X, Lu C, Pang Y, Zu X, Chen M, et al. Background, applications and challenges of radiogenomics in genitourinary tumor. Am J Cancer Res. 2021;11(5):1936–45.
77.
Zeng H, Chen L, Wang M, Luo Y, Huang Y, Ma X. Integrative radiogenomics analysis for predicting molecular features and survival in clear cell renal cell carcinoma. Aging (Albany NY). 2021;13(7):9960–75.CrossRef
78.
Zhao Y, Liu G, Sun Q, Zhai G, Wu G, Li ZC. Validation of CT radiomics for prediction of distant metastasis after surgical resection in patients with clear cell renal cell carcinoma: exploring the underlying signaling pathways. Eur Radiol. 2021;31(7):5032–40.CrossRef
79.
Liu P, Tan XZ, Zhang T, Gu QB, Mao XH, Li YC, et al. Prediction of microvascular invasion in solitary hepatocellular carcinoma ≤ 5 cm based on computed tomography radiomics. World J Gastroenterol. 2021;27(17):2015–24.CrossRef
80.
Liu Q, Li J, Xu L, Wang J, Zeng Z, Fu J, et al. Individualized prediction of colorectal cancer metastasis using a radiogenomics approach. Front Oncol. 2021;11: 620945.CrossRef
81.
Xie CY, Hu YH, Ho JWK, Han LJ, Yang H, Wen J, et al. Using genomics feature selection method in radiomics pipeline improves prognostication performance in locally advanced esophageal squamous cell carcinoma-A pilot study. Cancers (Basel). 2021;13(9):2145.CrossRef
82.
Di Giannatale A, Di Paolo PL, Curione D, Lenkowicz J, Napolitano A, Secinaro A, et al. Radiogenomics prediction for MYCN amplification in neuroblastoma: a hypothesis generating study. Pediatr Blood Cancer. 2021;68(9): e29110.CrossRef
83.
Habib A, Jovanovich N, Hoppe M, Ak M, Mamindla P, R Colen R, et al. MRI-based radiomics and radiogenomics in the management of low-grade gliomas: evaluating the evidence for a paradigm shift. J Clin Med. 2021;10(7):1411.CrossRef
84.
Zheng S, Tao W. Identification of novel transcriptome signature as a potential prognostic biomarker for anti-angiogenic therapy in glioblastoma multiforme. Cancers (Basel). 2021;13(5):1013.CrossRef
85.
Chen M, Yin F, Yu Y, Zhang H, Wen G. CT-based multi-phase radiomic models for differentiating clear cell renal cell carcinoma. Cancer Imaging. 2021;21(1):42.CrossRef
86.
Smedley NF, Aberle DR, Hsu W. Using deep neural networks and interpretability methods to identify gene expression patterns that predict radiomic features and histology in non-small cell lung cancer. J Med Imaging (Bellingham). 2021;8(3): 031906.
87.
Shim KY, Chung SW, Jeong JH, Hwang I, Park CK, Kim TM, et al. Radiomics-based neural network predicts recurrence patterns in glioblastoma using dynamic susceptibility contrast-enhanced MRI. Sci Rep. 2021;11(1):9974.CrossRef
88.
Kirienko M, Sollini M, Corbetta M, Voulaz E, Gozzi N, Interlenghi M, et al. Radiomics and gene expression profile to characterise the disease and predict outcome in patients with lung cancer. Eur J Nucl Med Mol Imaging. 2021;48(11):3643–55.CrossRef
89.
Yan J, Zhang S, Li KKW, Wang W, Li K, Duan W, et al. Incremental prognostic value and underlying biological pathways of radiomics patterns in medulloblastoma. EBioMedicine. 2020;61: 103093.CrossRef
90.
Huang Y, Zeng H, Chen L, Luo Y, Ma X, Zhao Y. Exploration of an integrative prognostic model of radiogenomics features with underlying gene expression patterns in clear cell renal cell carcinoma. Front Oncol. 2021;11: 640881.CrossRef
91.
Wang JH, Wahid KA, van Dijk LV, Farahani K, Thompson RF, Fuller CD. Radiomic biomarkers of tumor immune biology and immunotherapy response. Clin Transl Radiat Oncol. 2021;28:97–115.CrossRef
92.
Kim BC, Kim J, Kim K, Byun BH, Lim I, Kong CB, et al. Preliminary radiogenomic evidence for the prediction of metastasis and chemotherapy response in pediatric patients with osteosarcoma using 18F-FDF PET/CT, EZRIN and KI67. Cancers (Basel). 2021;13(11):2671.CrossRef
93.
Yi X, Liu Y, Zhou B, Xiang W, Deng A, Fu Y, et al. Incorporating SULF1 polymorphisms in a pretreatment CT-based radiomic model for predicting platinum resistance in ovarian cancer treatment. Biomed Pharmacother. 2021;133: 111013.CrossRef
94.
Park CJ, Han K, Kim H, Ahn SS, Choi D, Park YW, et al. MRI features may predict molecular features of glioblastoma in isocitrate dehydrogenase wild-type lower-grade gliomas. AJNR Am J Neuroradiol. 2021;42(3):448–56.CrossRef
95.
Li H, Zhu Y, Burnside ES, Huang E, Drukker K, Hoadley KA, et al. Quantitative MRI radiomics in the prediction of molecular classifications of breast cancer subtypes in the TCGA/TCIA data set. NPJ Breast Cancer. 2016;2:16012.CrossRef
96.
Zhao B. Understanding sources of variation to improve the reproducibility of radiomics. Front Oncol. 2021;11: 633176.CrossRef
97.
Miles K. Radiomics for personalised medicine: the long road ahead. Br J Cancer. 2020;122(7):929–30.CrossRef
98.
Lu L, Ahmed FS, Akin O, Luk L, Guo X, Yang H, et al. Uncontrolled confounders may lead to false or overvalued radiomics signature: a proof of concept using survival analysis in a multicenter cohort of kidney cancer. Front Oncol. 2021;11: 638185.CrossRef
Metadata
Title
A review of radiomics and genomics applications in cancers: the way towards precision medicine
Authors
Simin Li
Baosen Zhou
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Radiation Oncology / Issue 1/2022
Electronic ISSN: 1748-717X
DOI
https://doi.org/10.1186/s13014-022-02192-2

Other articles of this Issue 1/2022

Radiation Oncology 1/2022 Go to the issue

Research

Locally advanced NSCLC: a plea for sparing the ipsilateral normal lung—prospective, clinical trial with DART-bid (dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily) by VMAT

Study protocol

MR-guided adaptive stereotactic body radiotherapy (SBRT) of primary tumor for pain control in metastatic pancreatic ductal adenocarcinoma (mPDAC): an open randomized, multicentric, parallel group clinical trial (MASPAC)

Research

Safety of stereotactic body radiation therapy for localized prostate cancer without treatment planning MRI

Research

Monte Carlo simulation of linac using PRIMO

Research

Chemoradiation versus surgery for superficial esophageal squamous cell carcinoma after noncurative endoscopic submucosal dissection: comparison of long-term oncologic outcomes

Short report

A pilot study of machine-learning based automated planning for primary brain tumours